Spectrum Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference 2020
Spectrum Pharmaceuticals to Present Data from Phase 2 Clinical Trial for Poziotinib at Upcoming Medical Conference
Spectrum Pharmaceuticals to Present at the Barclays Global Healthcare Conference 2020
Spectrum Pharma (SPPI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Spectrum Pharmaceuticals Cancelled Participation in Upcoming Medical Conference Due to Coronavirus Pandemic
Spectrum Pharmaceuticals Reports First Quarter 2020 Financial Results and Pipeline Update
Spectrum Pharma (SPPI) misses bottom-line estimates for the first quarter and records no revenues.
Spectrum Pharmaceuticals Initiates Same Day Dosing Clinical Trial for ROLONTIS® (eflapegrastim)
Spectrum Pharmaceuticals to Report First Quarter 2020 Financial Results and Provide Corporate Update
Spectrum Pharmaceuticals (SPPI) closed the most recent trading day at $3.24, moving -1.52% from the previous trading session.
Q1 2020 Spectrum Pharmaceuticals Inc Earnings Call
Spectrum Pharmaceuticals Provides Strategy Update for Poziotinib Development Program
The Rosen Law Firm P.A. and Bronstein Gewirtz & Grossman, LLC announce that the United States District Court for the District of Nevada has approved the following announcement of a proposed class action settlement that would benefit purchasers of securities of Spectrum. TO: ALL PERSONS WHO PURCHASED OR ACQUIRED SPECTRUM PHARMACEUTICALS, INC. COMMON STOCK AND/OR CALL OPTIONS, AND/OR SOLD SPECTRUM PHARMACEUTICALS, INC. PUT OPTIONS, FROM JANUARY 31, 2013 THROUGH SEPTEMBER 16, 2016, BOTH DATES INCLUSIVE.
Progress of its pipeline candidates is likely to have increased Spectrum Pharmaceuticals' (SPPI) operating expenses in the fourth quarter.
Spectrum Pharmaceuticals Appoints Seth H.Z. Fischer to Board of Directors
At this time, I would like to welcome everyone to the Spectrum Pharmaceuticals First Quarter 2020 Earnings Call. Thank you for joining us today for Spectrum Pharmaceuticals' First Quarter 2020 Financial Results Conference Call. Joining me on the call today from Spectrum Pharmaceuticals will be Joe Turgeon, President and CEO; Kurt Gustafson, Chief Financial Officer; and Dr. Francois Lebel, Chief Medical Officer.
Spectrum Pharmaceuticals to Present Data from Phase 2 Clinical Trial for Poziotinib at AACR Virtual Annual Meeting
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Spectrum Pharma (SPPI) misses bottom-line estimates for the fourth quarter and records no revenues. Shares down.
Q4 2019 Spectrum Pharmaceuticals Inc Earnings Call